Several epidemiological reports are actually performed around the incidence of breast, endometrial, ovarian and cervical cancer in women working with oral contraceptives. The chance of getting breast cancer diagnosed could possibly be marginally elevated amongst present and recent end users of COCs. Even so, this excess threat appears to minimize a